![](https://healthfex-1124.u-paris-sciences.fr/wp-content/uploads/2025/02/EMaubec_Equipe1_GEMS_u1124-150x150.jpg)
Centre de Neurophysique, Physiologie et Pathologie - CNRS UMR 8119
Université Paris Descartes
45 Rue des Saints Pères
75270 Paris Cedex 06
France
Fax : +33 (0) 1 42 86 20 80
Eve Maubec
University Professor
Genetic Epidemiology and functional Genomics of Multifactorial Diseases, Genomic Epidemiology of Multifactorial DiseaseS
eve.maubec@-Code to remove to avoid SPAM-inserm.fr
Journal articles
2023
- ref_biblio
- Marion Rolland, Emmanuel Oger, Monica Dinulescu, Thierry Lesimple, David Russo, et al.. French dermatologists' opinions and practices with regard to adjuvant therapy in stage III melanoma. JEADV Clinical Practice, 2023, Jeadv Clinical Practice, 2 (4), pp.708-717. ⟨10.1002/jvc2.195⟩. ⟨hal-04357721⟩
- Accès au bibtex
-
2022
- ref_biblio
- Marguerite Kandel, Aurélie Bardet, Stéphane Dalle, Clara Allayous, Laurent Mortier, et al.. Cost-Effectiveness Analysis of Sequential Treatment Strategies for Advanced Melanoma in Real Life in France. Current Oncology, 2022, 29 (12), pp.9255-9270. ⟨10.3390/curroncol29120725⟩. ⟨hal-04049403⟩
- Accès au texte intégral et bibtex
-
2021
- ref_biblio
- Candice Hober, Lisa Fredeau, Anne Pham-Ledard, Marouane Boubaya, Florian Herms, et al.. Cemiplimab for locally advanced and metastatic cutaneous squamous-cell carcinomas: Real-life experience from the French CAREPI study group. Cancers, 2021, 13 (14), 14 p. ⟨10.3390/cancers13143547⟩. ⟨hal-03332168⟩
- Accès au texte intégral et bibtex
-
2020
- ref_biblio
- Sandra Huynh, Laurent Mortier, Caroline Dutriaux, Eve Maubec, Marie Boileau, et al.. Combined Therapy with Anti-PD1 and BRAF and/or MEK Inhibitor for Advanced Melanoma: A Multicenter Cohort Study. Cancers, 2020, 12 (6), pp.1666. ⟨10.3390/cancers12061666⟩. ⟨hal-03257701⟩
- Accès au texte intégral et bibtex
-
2008
- ref_biblio
- Fabienne Lesueur, Mahaut de Lichy, Michel Barrois, Guillermo Durand, Johny Bombled, et al.. The contribution of large genomic deletions at the CDKN2A locus to the burden of familial melanoma. British Journal of Cancer, 2008, 99 (2), pp.364-370. ⟨10.1038/sj.bjc.6604470⟩. ⟨hal-02196212⟩
- Accès au texte intégral et bibtex
-